Genomics bioinformatics platform developer PierianDx, a Washington University in St Louis spinout, has raised fresh capital to advance its business strategy.
PierianDx, a US-based genomic bioinformatics platform developer founded on Washington University in St Louis research, has closed a $27m series B round co-led by venture capital and private equity firm ATW Partners.
VC firm SJF Ventures co-led the round, with participation from national reference laboratory Arup Laboratories, healthcare provider Inova Health Systems, research services provider RTI International and Health Catalyst Capital.
Arup Laboratories is a nonprofit organisation created by Utah University to investigate disease on the basis of tissue analysis at a microscopic level.
Founded in 2014, PierianDx has created a medical diagnostics platform with informatics software tools that facilitate molecular-level genomic sequencing of the patient’s DNA to determine the best course of treatment.
The software fuses bioinformatics databases with high-throughput sequencing in order to give clinicians granular DNA insights, helping to flag up mutations responsible for disease.
PierianDx is the result of research led…